Yvonne Allinson, former chief executive officer of the Society of Hospital Pharmacists of Australia, was presented with the 2013 Fred J Boyd Award at the opening session of the SHPA’s 39th National Conference on Friday. The award, named after the founding president of SHPA, is the Society’s most prestigious honour and is presented every two years to an SHPA member who has made an outstanding contribution to hospital pharmacy in Australia. Allinson was the CEO of SHPA for 12 years, stepping down in Jan 2012 and continues to serve SHPA as an adviser in a part time capacity. The award recognises her “enormous and sustained contribution to the profession,” according to SHPA President Sue Kirsa, who’s pictured above presenting the plaque. “Yvonne’s unwavering commitment to patient care and to quality pharmacy services has resulted in SHPA becoming a strong and relevant organisation. “The strong member and patient-focused culture that Yvonne has nurtured within SHPA will enable the organisation to flourish and uphold the shared vision of all SHPA members,” Kirsa said. She quoted one of the nominators who said “Thanks to Yvonne, Australians are getting better pharmacy services”. During Allinson’s tenure at SHPA she led great change and growth in the organisation, Kirsa added, with SHPA’s current position and standing today being “a direct result of Yvonne’s passion, commitment and foresight and her ability to bring people along with her on this journey”. Recurring themes of Allinson’s career have included peer review and quality assurance for clinical pharmacists. She facilitated the development of the SHPA CPD program to help pharmacists participate in lifelong learning and provide improved services to their patients. While SHPA ceo Allinson also had significant input into many major changes in the profession, including PBS in hospitals, mandatory CPD, national guidelines and much more. SHPA said that Yvonne’s experience at the bedside as a clinical pharmacist, and her collaborative approach has “helped her to drive system-wide changes and improvements”.
THE Australian Consensus Framework for Ethical Collaboration in the Healthcare Sector was launched in Tokyo last week, with 50 signatories including Pharmacy Guild of Australia, SHPA, ASMI, CMA, CHF, Medicines Australia and NPS Medicinewise.